Clinical and Biochemical correlates of 18-FDG-PET/CT detected atherosclerotic plaque inflammation.

Clinical and Biochemical correlates of 18-FDG-PET/CT detected atherosclerotic plaque inflammation. - Correlates of atherosclerotic plaque inflammation

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON34581

Enrollment

150

Registered

2010-09-29

Start date

2010-10-19

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atherosclerosis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Being scheduled for 18-FDG-PET/CT examination at the VU university medical center

Exclusion criteria

Exclusion criteria: - The use of immunosuppressive or cytotoxic medication at or 1 month prior to the scan. - Inability to understand or unwillingness to provide informed consent. - Plasma glucose > 11 mmol/l at time of PET/CT-scan. - Suspected vasculitis as indication for PET/CT.

Design outcomes

Primary

Measure	Time frame
Correlation coefficients between clinical and biochemical cardiovascular risk factors and inflammatory markers on the one hand and plaque inflammation (measured as TBR) on the other hand.	—

Secondary

Measure	Time frame
n.a.	—

Countries

Netherlands

Outcome results